Sreenath:aml: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
(2 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
__NOTOC__ | __NOTOC__ | ||
==AML Project== | ==AML Project== | ||
== Purpose == | == Purpose == | ||
To understand the behavior of the signaling mechanism in hematopoietic disorders, in particular Acute Myelogenous Leukemia (AML) using Complex Systems Biology and a data rich flow cytometry approach. | To understand the behavior of the signaling mechanism in hematopoietic disorders, in particular Acute Myelogenous Leukemia (AML) using Complex Systems Biology and a data rich flow cytometry approach. | ||
== Participants == | == Participants == | ||
Line 27: | Line 28: | ||
Jayant Avva | Jayant Avva | ||
Yehong Huong | Yehong Huong (Jacobberger Lab) | ||
Radina P. Soebiyanto | Radina P. Soebiyanto | ||
Line 40: | Line 41: | ||
Akshai Singh | Akshai Singh | ||
Latest revision as of 16:12, 17 May 2007
CASE Complex Systems Biology Center
AML Project
Purpose
To understand the behavior of the signaling mechanism in hematopoietic disorders, in particular Acute Myelogenous Leukemia (AML) using Complex Systems Biology and a data rich flow cytometry approach.
Participants
Faculty & Staff
Professor James 'Jake' Jacobberger (Hematology/Oncology), Director of the Cytometry Core Facility
Professor Sree N. Sreenath (Electrical Engineering and Computer Science)
R. Michael Sramkoski, Manager of the Cytometry Core Facility
Students
Graduate
Jayant Avva
Yehong Huong (Jacobberger Lab)
Radina P. Soebiyanto
Michael C. Weis
Undergraduate
Arielle Kanters
Akshai Singh